Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 9

2.

[Late onset of medullary thyroid carcinoma with bilateral adrenal pheochromocytomas in the case of patient with MEN 2].

Zakrzewska A, Makowska AM, Bar-Andziak E.

Pol Merkur Lekarski. 2004 Dec;17(102):633-7. Polish.

PMID:
15771139
3.

Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes.

Munnes M, Fanaei S, Schmitz B, Muiznieks I, Holschneider AM, Doerfler W.

Am J Med Genet. 2000 Sep 4;94(1):19-27.

PMID:
10982477
4.

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. Epub 2007 Sep 25.

PMID:
17895320
5.

Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.

Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L.

Surgery. 2007 Jan;141(1):90-5. Epub 2006 Jul 31.

PMID:
17188172
6.

Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.

Chappuis-Flament S, Pasini A, De Vita G, Ségouffin-Cariou C, Fusco A, Attié T, Lenoir GM, Santoro M, Billaud M.

Oncogene. 1998 Dec 3;17(22):2851-61.

7.

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hüfner M, Wohllk N, Opocher G, Dvořáková S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorländer C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wüster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP; International RET Exon 10 Consortium.

Hum Mutat. 2011 Jan;32(1):51-8. doi: 10.1002/humu.21385.

PMID:
20979234
8.

Early malignant progression of hereditary medullary thyroid cancer.

Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H; European Multiple Endocrine Neoplasia (EUROMEN) Study Group.

N Engl J Med. 2003 Oct 16;349(16):1517-25.

9.

Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma.

Koch CA, Brouwers FM, Vortmeyer AO, Tannapfel A, Libutti SK, Zhuang Z, Pacak K, Neumann HP, Paschke R.

BMC Cancer. 2006 May 17;6:131.

Supplemental Content

Support Center